Scivanta Medical (OTCMKTS:SCVM) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.
Insider and Institutional Ownership
50.6% of Motus GI shares are owned by institutional investors. 34.0% of Scivanta Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
This table compares Scivanta Medical and Motus GI’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Motus GI||$40,000.00||2,048.48||-$22.26 million||($1.23)||-3.11|
Scivanta Medical has higher earnings, but lower revenue than Motus GI.
Risk and Volatility
Scivanta Medical has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Comparatively, Motus GI has a beta of 2.1, indicating that its stock price is 110% more volatile than the S&P 500.
This is a breakdown of current ratings for Scivanta Medical and Motus GI, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Motus GI has a consensus price target of $10.50, suggesting a potential upside of 174.87%. Given Motus GI’s higher possible upside, analysts plainly believe Motus GI is more favorable than Scivanta Medical.
This table compares Scivanta Medical and Motus GI’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Motus GI beats Scivanta Medical on 5 of the 8 factors compared between the two stocks.
Scivanta Medical Company Profile
Scivanta Medical Corporation does not have significant operations. Previously, it was engaged in the development, manufacture, and distribution of the Scivanta cardiac monitoring system. The company intends to acquire a new technology, product, or service. The company was formerly known as Medi-Hut Co., Inc. The company was founded in 1981 and is headquartered in Spring Lake, New Jersey.
Motus GI Company Profile
Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company is based in Fort Lauderdale, Florida.
Receive News & Ratings for Scivanta Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scivanta Medical and related companies with MarketBeat.com's FREE daily email newsletter.